{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03322",
      "entity_text" : "prothrombinase complex",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03317",
      "entity_text" : "Xa inhibitor",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Apixaban (Eliquis (R)) is a oral factor Xa inhibitor that impedes activity of factor Xa when free or bound to platelets, in a selective and reversible manner, and blocks activity of the prothrombinase complex.",
  "reading_complete" : "2020-08-04T14:03:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:02:39Z",
  "trigger" : "blocks",
  "evidence" : [ "Xa inhibitor that impedes activity of factor Xa when free or bound to platelets, in a selective and reversible manner, and blocks activity of the prothrombinase complex" ],
  "pmc_id" : "6375259",
  "score" : 0
}